Joanne Hawana

FDA Continues To Intentionally Incorporate AI Into Medical Product Development With Its Establishment Of A New Internal Advisory Body

CMS Issues Final Notice On Program For Breakthrough Device Reimbursement But Industry Looks To Congress For More Inclusive Solution

FDA Rolls Out Innovative New Designation Programs In Response To Congressional Mandates

FDA And CTTI Hold Joint Workshop On AI In Drug Development

FDA's Final LDT Rule Is Here, And The Changes Show The Agency Is Serious And Actually Listening To Stakeholders

FDA Warning Letter Is A Stark Reminder That If You Claim Your Product Is RUO, It Has To Be RUO

Health Law Diagnosed – A Discussion On The Regulatory Requirements For LDTs (Podcast)

FDA Faces Critical Deadlines In 2024, Even Without An Election Looming

White House Launches Initiative On Women's Health Research

Looking Back And Moving Forward: MoCRA Regulatory Developments Ring In The New Year